We extend their findings in EGFR-mutated lung adenocarcinoma cells and further demonstrate that B7-H3 deletion increases the susceptibility of lung adenocarcinoma cells to gefitinib. The gene discussed is EGFR; the disease is lung adenocarcinoma.